,,ii  #aag? ,,congress  #a/ ,session    
,s4 #cagd  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,novemb] #d1 #bjba,mr4 
,rubio 7= himself & ,ms4 ,w>r57         
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on ,arm$ 
,s]vices  ,a ,,bill  ,to implem5t !     
recomm5dations ( ! ,inspector ,g5]al ( !
 ,dep>tm5t ( ,def5se ) respect to       
mitigation ( =eign suppli]s 9 !         
ph>maceutical supply *a9 ( ! ,dep>tm5t (
 ,def5se4  #a4 ,%ort title ,?is ,act may
 be cit$ z ! ,/r5g!n+ ,supply ,*a9s =   
,s]vicememb]s & ,security ,act4  #b4    
,risk managem5t = ,dep>tm5t ( ,def5se   
supply *a9s  7a7 ,risk managem5t = all  
,dep>tm5t ( ,def5se supply *a9s ,n lat] 
?an #ahj days aft] ! date ( ! enactm5t (
 ?is ,act1 ! ,"u ,secret>y ( ,def5se =  
,acquisition & ,su/a9m5t %all-- 7#a7    
develop & issue implem5t+ guidance =    
risk managem5t = ,dep>tm5t ( ,def5se    
supply *a9s = mat]iel = ! ,dep>tm5t1    
includ+ ph>maceuticals2  7#b7 id5tify1 9
 coord9ation ) ! ,commission] ( ,food & 

,drugs1 supply *a9 in=mation gaps reg>d+
 reliance on =eign suppli]s ( drugs1    
includ+ active ph>maceutical +r$i5ts &  
f9al drug products2 &  7#c7 submit to   
,congress a report reg>d+-- 7,a7 exi/+  
in=mation /reams1 if any1 t may be us$  
to assess ! reliance by ! ,dep>tm5t (   
,def5se on high-risk =eign suppli]s (   
drugs2  7,b7 vuln]abilities 9 ! drug    
supply *a9s ( ! ,dep>tm5t ( ,def5se2 &  
7,c7 any recomm5dations to address-- 7i7
 in=mation gaps id5tifi$ "u p>agraph    
7#b72 &  7ii7 any risks relat$ to su*   
reliance on =eign suppli]s4  7b7 ,risk  
managem5t = ,dep>tm5t ( ,def5se         
ph>maceutical supply *a9 ,! ,director ( 
! ,def5se ,heal? ,ag5cy %all-- 7#a7 n   
lat] ?an "o ye> aft] ! issuance ( !     
guidance requir$ by subsection 7a77#a71 
develop & publi% implem5t+ guidance =   
risk managem5t = ! ,dep>tm5t ( ,def5se  
supply *a9 = ph>maceuticals2 &  7#b7    
e/abli% a work+ gr\p-- 7,a7 to assess   
risks to ! ph>maceutical supply *a92    
7,b7 to id5tify ! ph>maceuticals mo/    

critical to b5efici>y c>e at milit>y    
treatm5t facilities2 &  7,c7 to e/abli% 
policies = allocat+ sc>ce ph>maceutical 
res\rces 9 case ( a supply disruption4  
7c7 ,responsiv5ess te/+ ( ,def5se       
,logi/ics ,ag5cy ph>maceutical contracts
 ,! ,director ( ! ,def5se ,logi/ics     
,ag5cy %all modify ,def5se ,logi/ics    
,ag5cy ,in/ructions #ejbe4jc &          
#caaj4ja-- 7#a7 to require ,def5se      
,logi/ics ,ag5cy ,troop ,support to     
coord9ate annually ) cu/om]s 9 ! milit>y
 dep>tm5ts to conduct responsiv5ess te/+
 ( ! ,def5se ,logi/ics ,ag5cy's cont+5cy
 contracts = ph>maceuticals2 &  7#b7 to 
include ! results ( t te/+1 z report$ by
 cu/om]s 9 ! milit>y dep>tm5ts1 9 !     
annual reports ( ! ,w>/opp] ,program4